background
perinat
period
carri
highest
risk
stroke
childhood
howev
pathophysiolog
poorli
understood
prevent
prognost
therapeut
strategi
avail
new
pathophysiolog
model
describ
develop
neonat
arteri
ischem
stroke
nai
combin
result
prenat
inflamm
hypoxicischem
insult
neuroinflamm
system
inflammatori
respons
also
import
featur
nai
identifi
key
player
inflammatori
system
limelight
current
research
case
present
present
four
nai
case
detail
analysi
intracellular
plasma
cytokin
level
avail
first
month
life
neonat
admit
initi
diagnosi
hypox
ischem
encephalopathi
hie
howev
earli
mri
examin
reveal
nai
blood
sampl
collect
h
life
h
h
week
month
life
peripher
blood
mononuclear
cell
assess
flow
cytometri
plasma
cytokin
level
measur
pool
data
cohort
four
nai
patient
compar
infant
hie
h
age
preval
lymphocyt
remain
lower
nai
h
lymphocyt
nai
produc
h
cell
produc
sever
hie
nai
product
remain
elev
cell
month
nai
decreas
hie
week
preval
lymphocyt
prone
enter
cn
elev
nai
hand
month
age
preval
lymphocyt
decreas
nai
compar
hie
h
found
elev
plasma
level
nai
month
plasma
level
decreas
nai
remain
elev
hie
conclus
differ
cytokin
network
present
nai
hie
lymphocyt
appear
shift
toward
proinflammatori
direct
nai
inflammatori
respons
appear
pronounc
h
nai
decreas
faster
reach
lower
plasma
level
inflammatori
marker
month
perinat
period
carri
highest
risk
stroke
entir
childhood
almost
similar
incid
elderli
popul
perinat
stroke
broad
term
defin
group
heterogen
condit
character
focal
disrupt
cerebr
blood
flow
neonat
arteri
ischem
stroke
nai
one
common
subtyp
incid
live
birth
nai
definit
arteri
ischem
stroke
clinic
symptom
occur
neonat
period
within
first
day
life
support
radiolog
evid
nai
gener
occur
term
neonat
present
major
risk
lifelong
motor
cognit
andor
behavior
disabl
rang
fine
motor
impair
unilater
cerebr
palsi
develop
around
affect
neonat
thu
nai
lead
caus
cerebr
palsi
interestingli
almost
case
nai
intracrani
arteri
develop
carotid
arteri
tree
affect
ie
proxim
part
anterior
cerebr
arteri
aca
middl
cerebr
arteri
mca
posterior
cerebr
arteri
pca
basilar
arteri
extracrani
arteri
left
unaffect
area
left
mca
common
local
ischem
lesion
result
higher
incid
rightsid
congenit
hemiplegia
clinic
present
nai
often
subtl
nonspecif
frequent
symptom
seizur
gener
hypotonia
lethargi
poor
feed
make
time
diagnosi
nai
difficult
diagnosi
nai
often
delay
due
prenat
onset
absenc
specif
sign
therefor
primari
focu
regard
therapeut
intervent
focus
prevent
postinsult
antiinflammatori
mechan
anoth
challeng
regard
diagnosi
nai
fact
risk
factor
clinic
sign
global
hypoxicischem
encephalopathi
hie
due
perinat
asphyxia
show
signific
overlap
nai
two
often
cooccur
differenti
two
syndrom
complex
question
studi
list
perinat
asphyxia
independ
risk
factor
nai
neuroinflamm
follow
ischemia
appear
common
featur
two
pathophysiolog
nai
poorli
understood
diseasespecif
prevent
measur
prognost
factor
therapeut
strategi
avail
risk
factor
nai
appear
specif
perinat
period
clearli
distinguish
risk
factor
stroke
older
children
adult
major
risk
factor
congenit
heart
diseas
bacteri
mening
held
account
approxim
nai
occurr
howev
case
nai
thought
multifactori
case
identifi
risk
factor
present
casecontrol
studi
aim
specifi
risk
factor
howev
number
case
rel
low
littl
consist
observ
matern
obstetr
neonat
risk
factor
independ
risk
factor
appear
casecontrol
studi
perinat
inflamm
genet
prothrombot
disord
found
associ
frequenc
nai
accord
classic
pathophysiolog
hypothesi
ischem
lesion
result
thromboembol
event
presum
sourc
thrombi
placenta
umbil
vessel
instanc
could
case
hypothesi
give
plausibl
explan
nai
almost
exclus
affect
intracrani
arteri
territori
develop
carotid
arteri
tree
incid
basilari
arteri
extracerebr
infarct
neglig
addit
angiograph
evid
indic
possibl
local
arteri
wall
defect
situ
thrombu
gener
base
find
giraud
et
al
propos
differ
pathomechan
maternofet
inflamm
induc
focal
arter
specif
intracrani
arteri
develop
carotid
arteri
tree
suscept
nai
use
preclin
rat
model
chorioamnion
abl
demonstr
classic
prothrombot
stress
appli
alon
mca
enough
induc
nai
howev
combin
utero
exposur
inflammationinduc
agent
lp
stress
lead
classic
symptom
nai
motor
impair
also
examin
wall
arteri
suscept
nai
found
constitut
express
certain
proinflammatori
cytokin
ie
higher
suscept
intracerebr
arteri
compar
extracerebr
arteri
furthermor
pup
born
lpsexpos
dam
develop
specif
cerebr
arter
increas
presenc
inflammatori
cell
macrophag
elev
level
proinflammatori
cytokin
increas
receptor
antagonist
ra
ratio
nai
suscept
arteri
elsewher
base
preclin
find
new
pathophysiolog
hypothesi
rais
consid
complex
bidirect
relationship
coagul
inflammatori
pathway
describ
develop
nai
result
multipl
hit
mechan
origin
perinat
inflamm
hypoxiaischemia
hi
giraud
et
al
identifi
three
major
risk
factor
combin
could
lead
nai
maternofet
inflamm
lead
focal
arter
arteri
suscept
nai
ii
window
suscept
develop
neonat
brain
iii
physiolog
procoagulatori
state
perinat
period
aggrav
inflammatori
respons
prenat
exposur
inflamm
appear
sensit
brain
postnat
hi
injuri
inflamm
could
matern
placent
fetal
origin
line
propos
risk
factor
nai
preeclampsia
chorioamnion
matern
fever
infect
addit
initi
hypox
insulta
commonli
recognizedi
follow
gener
neuroinflammatori
respons
initi
hypox
insult
lead
primari
energi
failur
necrosi
subsequ
glutam
releas
oxid
stress
result
excitotox
widespread
necrosi
necroptosi
within
first
h
insult
neural
tissu
damag
could
aggrav
previou
sensit
due
inflamm
could
lead
increas
oxid
stress
increas
product
proinflammatori
cytokin
second
phase
neuroinflamm
occur
h
initi
hi
insult
character
product
inflammatori
cytokin
migrat
leukocyt
brain
tissu
consequ
apoptosi
identifi
key
player
neuroinflammatori
apoptot
pathway
second
phase
could
import
time
target
intervent
inflammatori
cell
detect
week
even
month
follow
hi
insult
sustain
inflammatori
statu
consid
tertiari
latent
phase
inflammatori
respons
could
also
import
regard
neurolog
outcom
primari
aim
current
research
field
perinat
stroke
gain
better
understand
pathomechan
diseas
specif
regard
activ
inflammatori
pathway
could
present
possibl
specif
diagnosi
intervent
even
prevent
human
experiment
data
inflammatori
marker
scarc
one
casecontrol
studi
avail
aim
describ
level
differ
cytokin
plasma
nai
patient
elev
level
observ
month
follow
acut
ischem
stroke
ai
compar
healthi
control
howev
differ
observ
solubl
endotheli
protein
c
receptor
sepcr
fviii
median
level
limit
studi
includ
neonat
pediatr
stroke
case
birth
year
age
view
clinic
distinct
syndrom
result
indic
ongo
inflamm
could
observ
month
follow
ai
howev
inform
avail
regard
acut
phase
nai
pivot
role
inflammatori
pathway
ischem
brain
injuri
support
recent
year
research
data
lymphocyt
appear
play
central
role
ischem
infarct
develop
appear
brain
tissu
within
hour
hypox
insult
detect
month
injuri
cell
defici
shown
result
smaller
infarct
size
improv
neurolog
outcom
murin
model
sever
cytokin
connect
acut
ischem
stroke
adult
proinflammatori
cytokin
appear
exacerb
cerebr
injuri
adult
wherea
antiinflammatori
cytokin
appear
neuroprotect
although
immun
system
neonat
show
mani
differ
compar
adult
inflammatori
network
appear
play
similarli
critic
role
ischem
brain
injuri
therefor
reason
hypothes
cytokin
might
also
influenc
cours
neuroinflamm
neonat
brain
paper
present
four
nai
case
detail
analysi
intracellular
plasma
cytokin
level
avail
immedi
birth
first
month
age
knowledg
inform
avail
human
nai
therefor
data
present
could
serv
basi
futur
largerscal
casecontrol
studi
neonat
admit
region
cool
center
initi
diagnosi
hie
requir
therapeut
hypothermia
elig
cool
assess
accord
tobi
criteria
hypothermia
initi
h
life
rectal
temperatur
maintain
intervent
period
clinic
cultureproven
sepsi
detect
infant
infant
receiv
regular
prevent
intraven
antibiot
ie
ampicillin
gentamicin
hypotherm
treatment
mri
data
interpret
radiologist
blind
clinic
statu
neonat
base
criteria
defin
rutherford
et
al
total
term
neonat
enrol
written
parent
consent
studi
focus
inflammatori
chang
hie
approv
hungarian
medic
research
council
tukeb
four
infant
diagnos
nai
mri
scan
complet
one
infant
exclud
due
suspect
metabol
diseas
hie
group
data
neonat
analyz
divid
two
group
base
sever
hypoxicischem
encephalopathi
group
determin
base
initi
amplitudeintegr
eeg
aeeg
record
recoveri
time
monitor
togeth
mri
scan
perform
within
first
week
life
sever
group
n
form
newborn
moderatetosever
hie
sign
mri
scan
burstsuppress
continu
extrem
low
voltag
flat
trace
background
activ
aeeg
normal
aeeg
hour
life
never
earli
death
day
neonat
met
none
abovelist
criteria
constitut
moder
group
n
mild
hie
sign
mri
scan
continu
discontinu
normal
voltag
background
activ
aeeg
normal
aeeg
activ
hour
life
pool
data
cohort
four
nai
patient
compar
infant
hie
sever
hie
group
three
infant
deceas
month
age
due
sever
insult
avail
data
neonat
includ
relev
time
point
within
sever
group
therefor
data
miss
case
two
infant
data
miss
one
infant
clinic
characterist
infant
summar
tabl
two
millilit
venou
blood
collect
h
life
admiss
well
h
h
week
life
adjust
blood
sampl
requir
clinic
care
venou
blood
sampl
obtain
month
age
routin
outpati
followup
appoint
plasma
separ
peripher
blood
sampl
centrifug
plasma
sampl
aliquot
immedi
frozen
store
later
determin
cytokin
concentr
remain
cell
resuspend
rpmi
roswel
park
memori
institut
medium
sigmaaldrich
st
loui
mo
usa
cell
incub
pma
phorbol
ngml
ionomycin
bfa
brefeldin
h
allow
intracellular
accumul
cytokin
surfac
marker
stain
sampl
incub
follow
fluorochromeconjug
antihuman
monoclon
antibodi
phycoerythrincyanin
allophycocyanincyanin
panel
percp
peridininchlorophyllprotein
panel
accord
manufactur
instruct
biolegend
san
diego
ca
usa
red
blood
cell
lyse
pbmc
permeabil
use
facslys
facspermeabil
solut
bd
bioscienc
san
jose
ca
usa
cell
wash
resuspend
pb
phosphat
buffer
salin
divid
two
equal
aliquot
stain
accord
manufactur
instruct
intracellular
cytokin
use
follow
conjug
antihuman
monoclon
antibodi
appropri
isotyp
control
pe
phycoerythrin
percp
apc
allophycocyanin
fitc
fluorescein
isothiocyan
panel
pe
apc
fitc
panel
respect
biolegend
follow
label
cell
wash
resuspend
pb
flow
cytometri
analysi
sampl
analyz
immedi
facsaria
flow
cytomet
bd
bioscienc
equip
excit
laser
data
process
use
facsdiva
softwar
bd
bioscienc
one
hundr
thousand
cell
record
evalu
flow
cytometri
data
blind
clinic
statu
neonat
plasma
sampl
store
analysi
plasma
level
follow
cytokin
chemokin
growth
factor
determin
use
bioplex
pro
assay
biorad
laboratori
hercul
ca
usa
gcsf
nai
case
present
case
first
patient
admit
follow
emerg
cesarean
section
perform
due
oligohydramnio
fetal
tachycardia
week
gestat
matern
histori
chorioamnion
howev
mother
smoke
pregnanc
amniot
fluid
stain
thick
meconium
neonat
born
apgar
score
requir
intub
ventil
birth
first
capillari
blood
ga
show
lactic
acidosi
ph
mmoll
lactat
mmoll
becam
irrit
gener
increas
muscl
tone
thu
hypotherm
treatment
initi
second
day
life
present
symptom
characterist
pulmonari
hypertens
resolv
day
inhal
extub
day
life
earli
neurodevelopment
examin
show
mild
central
hypotonia
cranial
mri
diffusionweight
imag
perform
day
life
show
distinct
mm
area
ischemia
decreas
diffus
left
thalamu
evid
bleed
mr
spectroscopi
show
decreas
metabolit
correl
minim
hypoxicischem
encephalopathi
second
neonat
admit
follow
emerg
cesarean
section
due
complet
placent
abrupt
week
gestat
born
apgar
score
time
birth
heartrat
respiratori
effort
hypoton
pale
follow
bag
mask
ventil
heartrat
normal
howev
gasp
could
observ
intub
later
becam
irrit
initi
blood
ga
show
sever
metabol
acidosi
ph
chest
xray
perform
show
pneumothorax
right
side
drain
hypotherm
treatment
initi
due
sever
anemia
low
blood
pressur
requir
blood
transfus
two
occas
inotrop
support
day
respect
earli
neurodevelopment
examin
indic
grossli
abnorm
central
peripher
tone
distribut
cranial
mri
perform
day
life
diffusionweight
imag
show
larg
area
ischemia
decreas
diffus
area
left
middl
cerebr
arteri
sever
smaller
lesion
area
right
middl
cerebr
arteri
area
left
pariet
cortex
blur
hyperintens
signal
subcort
sign
bleed
tof
mri
angiographi
show
mark
irregular
significantli
decreas
blood
flow
particularli
left
mca
mri
sign
hypoxicischem
encephalopathi
present
third
neonat
born
uncompl
pregnanc
week
gestat
apgar
score
neonat
hypoton
spontan
breath
therefor
intub
first
gasp
breath
observ
min
birth
remain
gener
hypoton
first
blood
ga
show
sever
lactic
acidosi
ph
mmoll
lactat
mmoll
therapeut
hypothermia
commenc
initi
aeeg
record
show
abnorm
background
activ
howev
normal
hour
earli
neurodevelopment
examin
report
moder
gener
hypotonia
cranial
mri
perform
day
life
diffusionweight
imag
show
small
mm
ischem
lesion
decreas
diffus
right
thalamu
sign
ischemia
bleed
sign
hypox
ischem
encephalopathi
could
observ
fourth
neonat
born
uncompl
pregnanc
week
gestat
emerg
cesarean
section
due
immin
intrauterin
asphyxia
born
apgar
score
flaccid
sign
spontan
breath
heart
rate
follow
bag
mask
ventil
spontan
breath
note
min
neonat
remain
hypotens
areflex
intub
hypotherm
treatment
initi
aeeg
record
show
sign
seizur
initi
blood
ga
show
mix
acidosi
ph
initi
neurodevelopment
examin
demonstr
abnorm
central
peripher
tone
distribut
cranial
mri
perform
day
life
diffusionweight
imag
show
decreas
diffus
indic
ischemia
area
right
posterior
cerebr
arteri
smaller
lesion
present
right
thalamu
left
parietooccipit
area
sign
bleed
hypox
ischem
encephalopathi
present
h
age
preval
lymphocyt
remain
lower
nai
sever
hie
group
although
preval
lymphocyt
remain
consist
lower
nai
differ
reach
signific
level
time
point
contrari
preval
higher
h
nai
compar
moder
hie
preval
cell
show
elev
tendenc
h
nai
howev
valu
reach
signific
could
due
small
popul
week
preval
lymphocyt
prone
enter
cn
lymphocyt
elev
nai
compar
hie
group
also
compar
time
point
within
nai
group
fig
hand
month
age
preval
lymphocyt
decreas
nai
compar
hie
data
shown
tabl
h
preval
lymphocyt
higher
nai
sever
hie
cell
express
higher
level
nai
moder
hie
level
cell
highest
h
decreas
significantli
h
within
nai
group
mean
fluoresc
intens
mfi
lymphocyt
nai
highest
h
decreas
significantli
h
reach
lower
level
nai
either
hie
group
mfi
cell
higher
h
sever
hie
nai
interestingli
month
mfi
decreas
hie
group
rose
nai
data
shown
tabl
found
differ
nai
hie
intracellular
product
cell
howev
cytokin
appear
import
differenti
mild
sever
form
hie
h
found
mark
inflammatori
respons
nai
character
elev
plasma
level
compar
hie
plasma
level
highest
h
nai
month
howev
inflammatori
respons
appear
decreas
nai
compar
hie
indic
decreas
plasma
level
fig
level
lower
month
h
nai
found
alter
nai
plasma
level
gcsf
gmcsf
vcam
compar
hie
data
shown
tabl
contribut
lymphocyt
ischem
brain
injuri
appear
clear
cell
appear
cn
alreadi
hour
ischem
insult
accumul
cell
peak
around
day
follow
injuri
inhibit
cell
traffick
cn
decreas
deleteri
consequ
neuroinflamm
data
murin
stroke
model
show
persist
presenc
cell
week
ischem
attack
nai
patient
lymphocyt
appear
show
fig
alter
preval
cell
within
popul
first
month
life
moder
n
sever
n
hypoxicischem
encephalopathi
hie
nai
n
horizont
line
median
box
interquartil
rang
whisker
rang
p
vs
h
b
vs
h
c
vs
h
differ
cytokin
product
pattern
hie
promin
proinflammatori
respons
nai
h
cell
nai
patient
produc
higher
level
proinflammatori
neonat
moder
hie
cell
preval
nai
sever
hie
h
cell
neonat
sever
hie
produc
higher
level
proinflammatori
cell
nai
patient
known
import
factor
earli
phase
hie
differ
could
reflect
aggrav
neuroinflamm
sever
hie
hand
also
describ
neurotroph
neuroregen
antiinflammatori
properti
within
brain
alter
intracellular
level
cell
becom
revers
month
remain
elev
nai
wherea
decreas
hie
group
indic
sustain
level
might
present
longer
time
nai
line
literari
data
therefor
may
exert
neuroprotect
effect
longer
period
time
nai
plasma
cytokin
level
also
indic
differ
nai
hie
higher
level
proinflammatori
respons
h
nai
hie
found
elev
level
nai
see
tabl
detail
found
elev
follow
ischem
insult
utero
lp
exposur
chorioamnion
associ
perinat
stroke
murin
model
found
elev
level
h
compar
h
valu
nai
moder
hie
support
previou
data
emphas
role
utero
inflamm
plasma
level
preval
proinflammatori
cell
known
increas
week
adult
acut
ischem
stroke
decreas
month
line
find
found
higher
level
second
overal
plasma
level
sever
cytokin
appear
decreas
month
age
nai
appear
remain
higher
level
hie
also
found
alter
antiinflammatori
pathway
thought
primarili
produc
lymphocyt
howev
trandem
et
al
demonstr
murin
model
viru
enceph
highli
activ
cytotox
cell
also
import
sourc
peak
inflammatori
respons
data
suggest
cell
autoregul
activ
product
inflammatori
respons
reach
certain
level
primarili
local
effect
prevent
tissu
damag
express
cell
rapidli
decreas
day
cell
continu
express
least
day
data
show
significantli
higher
preval
lymphocyt
sever
hie
nai
first
h
life
cell
also
preval
mild
hie
nai
howev
differ
signific
lower
preval
cell
time
produc
proinflammatori
cytokin
could
lead
promin
proinflammatori
cytolyt
respons
decreas
autoregulatori
product
cell
nai
first
h
anoth
interpret
could
decreas
level
product
cell
reflect
utero
inflammatori
respons
decreas
time
birth
support
hypothesi
nai
found
elev
preval
lymphocyt
known
produc
month
follow
insult
altogeth
appear
product
differ
cell
subpopul
nai
hie
manipul
pathway
could
interest
explor
neuroprotect
point
view
preval
cell
major
regulatori
treg
cell
also
differ
nai
hie
one
import
cytokin
regul
cn
repair
found
increas
express
popul
nai
week
compar
h
hie
group
reflect
higher
capac
cell
enter
cn
meanwhil
preval
entir
popul
decreas
month
nai
compar
hie
appear
line
plasma
cytokin
data
show
increas
inflammatori
respons
nai
second
phase
neuroinflamm
could
follow
earlier
repar
phase
decreas
inflammatori
respons
month
age
therapeut
hypothermia
current
standard
care
term
neonat
hie
substanti
evid
support
role
hypothermia
reduc
mortal
improv
neurolog
outcom
infant
hypox
ischem
encephalopathi
notabl
evid
anim
focal
cerebr
ischemia
model
support
role
hypothermia
reduct
infarct
size
data
suggest
hypothermia
might
reduc
risk
seizur
perinat
stroke
thu
improv
outcom
therefor
intens
discuss
scientif
commun
extend
guidelin
includ
new
categori
therapeut
hypothermia
preterm
hie
perinat
stroke
howev
mani
issu
remain
address
base
result
previou
studi
one
mechan
behind
neuroprotect
effect
hypothermia
may
reduct
system
inflammatori
respons
seen
reduc
level
cytokin
hie
patient
treat
hypothermia
compar
normothermia
group
therefor
like
hypothermia
may
similarli
reduc
cytokin
level
follow
nai
main
limit
data
small
number
case
howev
could
provid
hypothesi
futur
larger
casecontrol
studi
anoth
limit
lack
healthi
control
popul
howev
due
ethic
consider
larg
number
blood
sampl
enrol
healthi
neonat
possibl
also
saw
notabl
variat
certain
plasma
cytokin
level
like
result
rel
instabl
plasma
cytokin
level
basi
primarili
focus
intracellular
cytokin
product
current
studi
valu
data
studi
could
lie
provid
incent
clinic
research
factor
enabl
differenti
two
disord
often
present
similar
symptom
birth
gain
better
understand
underli
pathophysiolog
factor
main
aim
current
stage
research
nai
lymphocyt
appear
show
shift
proinflammatori
direct
nai
compar
hie
elev
product
proinflammatori
h
decreas
autoregulatori
product
first
day
elev
product
month
altogeth
inflammatori
respons
appear
higher
h
nai
hie
appear
decreas
faster
indic
lower
level
inflammatori
marker
month
nai
hie
data
indic
similar
observ
adult
ai
also
support
hypothesi
ongo
utero
inflamm
prior
nai
clinic
research
area
pivot
better
understand
pathophysiolog
could
lead
identifi
specif
factor
distinguish
hie
nai
earli
could
open
new
pathway
prevent
individu
care
